Nestorov I - Search Results

1

Population pharmacokinetic analysis and simulation of the time-concentration profile of etanercept in pediatric patients with juvenile rheumatoid arthritis.

Yim DS, Zhou H, Buckwalter M, Nestorov I, Peck CC, Lee H. Yim DS, et al. Among authors: nestorov i. J Clin Pharmacol. 2005 Mar;45(3):246-56. doi: 10.1177/0091270004271945. J Clin Pharmacol. 2005. PMID: 15703360

2

Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysis.

Lee H, Kimko HC, Rogge M, Wang D, Nestorov I, Peck CC. Lee H, et al. Among authors: nestorov i. Clin Pharmacol Ther. 2003 Apr;73(4):348-65. doi: 10.1016/s0009-9236(02)17635-1. Clin Pharmacol Ther. 2003. PMID: 12709725 Clinical Trial.

3

Highlights from a recent BIO survey on therapeutic protein-drug interactions.

Pharmacokinetics and Disposition Expert Working Group Drug-Drug Interaction Taskforce; Lloyd P, Zhou H, Theil FP, Kakkar T, Nestorov I, Roberts SA. Pharmacokinetics and Disposition Expert Working Group Drug-Drug Interaction Taskforce, et al. Among authors: nestorov i. J Clin Pharmacol. 2012 Nov;52(11):1755-63. doi: 10.1177/0091270011424144. Epub 2011 Dec 13. J Clin Pharmacol. 2012. PMID: 22167564 No abstract available.

4

Pharmacokinetics of subcutaneously administered etanercept in subjects with psoriasis.

Nestorov I, Zitnik R, DeVries T, Nakanishi AM, Wang A, Banfield C. Nestorov I, et al. Br J Clin Pharmacol. 2006 Oct;62(4):435-45. doi: 10.1111/j.1365-2125.2006.02581.x. Br J Clin Pharmacol. 2006. PMID: 16995864 Free PMC article. Clinical Trial.

5

Modeling the exposure-response relationship of etanercept in the treatment of patients with chronic moderate to severe plaque psoriasis.

Hutmacher MM, Nestorov I, Ludden T, Zitnik R, Banfield C. Hutmacher MM, et al. Among authors: nestorov i. J Clin Pharmacol. 2007 Feb;47(2):238-48. doi: 10.1177/0091270006295062. J Clin Pharmacol. 2007. PMID: 17244775

6

Pharmacokinetics and biological activity of atacicept in patients with rheumatoid arthritis.

Nestorov I, Munafo A, Papasouliotis O, Visich J. Nestorov I, et al. J Clin Pharmacol. 2008 Apr;48(4):406-17. doi: 10.1177/0091270008315312. Epub 2008 Feb 26. J Clin Pharmacol. 2008. PMID: 18303125 Clinical Trial.

7

Population pharmacokinetic modeling of subcutaneously administered etanercept in patients with psoriasis.

Nestorov I, Zitnik R, Ludden T. Nestorov I, et al. J Pharmacokinet Pharmacodyn. 2004 Dec;31(6):463-90. doi: 10.1007/s10928-005-5912-0. J Pharmacokinet Pharmacodyn. 2004. PMID: 16222785

8

The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis.

Don BR, Spin G, Nestorov I, Hutmacher M, Rose A, Kaysen GA. Don BR, et al. Among authors: nestorov i. J Pharm Pharmacol. 2005 Nov;57(11):1407-13. doi: 10.1211/jpp.57.11.0005. J Pharm Pharmacol. 2005. PMID: 16259772

9

Population-Based Pharmacokinetic and Exposure-Efficacy Analyses of Peginterferon Beta-1a in Patients With Relapsing Multiple Sclerosis.

Hu X, Hang Y, Cui Y, Zhang J, Liu S, Seddighzadeh A, Deykin A, Nestorov I. Hu X, et al. Among authors: nestorov i. J Clin Pharmacol. 2017 Aug;57(8):1005-1016. doi: 10.1002/jcph.883. Epub 2017 Apr 10. J Clin Pharmacol. 2017. PMID: 28394418 Free PMC article. Clinical Trial.

10

Whole body pharmacokinetic models.

Nestorov I. Nestorov I. Clin Pharmacokinet. 2003;42(10):883-908. doi: 10.2165/00003088-200342100-00002. Clin Pharmacokinet. 2003. PMID: 12885263 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters